权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Etiology and Outcomes of Meningitis in Rural, Northern Uganda

乌干达北部农村地区脑膜炎的病因和结果

基本信息

批准号：
10693970
负责人：
Paul R Bohjanen
金额：
$ 16.26万
依托单位：
UNIVERSITY OF ROCHESTER
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-09-01 至 2025-04-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10693970
关键词：
Acquired Immunodeficiency Syndrome Adult Affect Africa Africa South of the Sahara Antifungal Agents Antigens Area Bacteria Bacterial Meningitis Blindness Caring Cessation of life Child Communicable Diseases Country Cryptococcal Meningitis Cryptococcus Cryptococcus neoformans Diagnosis Disease Outbreaks Early Diagnosis Educational workshop Epidemic Ethiopia Etiology Freezing Genes Goals Grant HIV HIV Seropositivity Health Personnel Health care facility Healthcare Hospital Referrals Hospitals Human Resources Human immunodeficiency virus test Impaired cognition Infant Infrastructure Joints Laboratories Latex Fixation Tests Manuscripts Measures Meningitis Methodology Microbiology Minnesota Neurologic Neurologic Deficit Nucleic Acid Amplification Tests Outcome Patient Admission Patients Persons Public Health Quality of life Rehabilitation therapy Reporting Resource-limited setting Risk Rural Sampling Senegal Services Signs and Symptoms Tuberculosis Uganda Universities Vaccines Virus Yeasts antigen test antiretroviral therapy deafness design diagnostic value disability experience fungus global health hearing impairment improved improved outcome lateral flow assay long-term sequelae mortality next generation sequencing outbreak control premature prevent programs routine Bacterial stain standard of care treatment optimization treatment program

项目摘要

Our long-term goal is to improve outcomes from meningitis in rural, northern Uganda, an area within the meningitis belt of Africa, where there has been poor infrastructure related to the diagnosis and management of meningitis. Each year, approximately five million people worldwide are affected by meningitis. According to the WHO, the estimated number of annual deaths related to meningitis is 300,000, with infants and children at greatest risk. A global health initiative to defeat meningitis by 2030 was developed by the WHO and partners. The key goals are to: a) eliminate epidemics of bacterial meningitis (BM), b) reduce cases and deaths from vaccine-preventable BM, and c) reduce disability and improve quality of life. In 2017, we developed a CM diagnosis and treatment program (CM-DTP) at Lira Regional Referral Hospital (LRRH) in rural, northern Uganda as a quality improvement initiative designed to improve the diagnosis and treatment of CM. This ongoing program is a joint effort by collaborators on this application: University of Minnesota (UMN), the Infectious Diseases Institute (IDI) at Makerere University, and Lira University/LRRH. Through the CM-DTP, patients admitted to LRRH with signs and symptoms of meningitis undergo rapid HIV testing, HIV-positive patients then undergo rapid cryptococcal antigen (CrAg) testing, and patients diagnosed with CM receive standard of care antifungal treatment. Although this program was effective at improving the diagnosis and treatment of CM, the program also pointed out major gaps in meningitis care related to the diagnosis and treatment of meningitis due etiologies other than CM. Of 281 adult patients who presented with meningitis at LRRH from 2017 to 2019, we diagnosed CM in 99 (35.2%), but the etiology of meningitis for the other 64.8% of patients was unknown, due to lack of diagnostic capabilities. The specific aims are directed at improving infrastructure for the diagnosis and treatment of meningitis by building microbiology laboratory capacity, directing treatments at etiologies, and educating health care workers. Aim 1 is to identify the etiology of meningitis in 400 patients at LRRH through expanded microbiology laboratory capacity developed through this grant, aim 2 is to direct treatment of patients with meningitis based on etiology, and for each etiology, track outcomes including death, cognitive impairment and neurological deficits, and aim 3 is to build human resources capacity among health care workers to identify, diagnose, and treat meningitis at LRRH, Lira University, and surrounding health facilities. This project will build microbiology laboratory and human resources capacity for the diagnosis and treatment of meningitis in Lira and will provide vital information about the burden, etiology, and outcomes of meningitis in a setting that is representative of many resource-limited regions in rural SSA. Building capacity to diagnose different etiologies of meningitis at Lira University/LRRH will allow recognition of meningitis outbreaks in the area if they should occur and allow public health measures, such as vaccines or mitigation efforts, to be implemented for outbreak control.

我们的长期目标是改善乌干达北部农村地区脑膜炎的治疗效果